Navigation Links
Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations
Date:4/8/2009

nstitution in combination with the prevention of acute GvHD in bone marrow transplantations using a mismatched donor.

Dr. Denis-Claude Roy, Head of Stem Cell Therapy of the Hospital Maisonneuve-Rosemont, Montreal, Canada says: "These are fascinating results, demonstrating the feasibility of performing mismatched transplantations with an ATIR(TM) infusion. These results may give hope to patients who currently cannot be treated because of limited donor availability. In the future ATIR(TM) may allow mismatched transplantations to be performed in virtually all patients who cannot find a donor thereby improving the outcome of the whole procedure."

Dr. Manja Bouman, CEO of Kiadis Pharma, says: "Kiadis Pharma is pleased with the election of our ATIR(TM) data to be presented at the Presidential Symposium of the EBMT. It shows the interest in our approach by the medical community. On the basis of these highly encouraging results we are currently preparing for a multinational registration study with ATIR(TM) in mismatched transplantation procedures."

Go to http://www.kiadis.com for the complete press release


'/>"/>
SOURCE Kiadis Pharma
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
2. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
3. EMEA Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation
4. Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
5. Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc
6. Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
7. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
8. Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft
9. New Pharmaxis Board Appointment
10. Pharmaxis Investor Conference Call
11. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...EBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna...mpany"), a global biopharmaceutical company focuse...ed that the U.S. Food and Drug Administration (FDA...ny,s PI3K/Akt pathway inhibitor compound, perifosi...ctory multiple myeloma. Keryx Biopharmaceuticals, ...
(Date:12/1/2009)...LINE VILLAGE, Nev., Dec. 1 /PRNewswire-FirstCall/ ...y announced revenue guidance for the fourth quarte...lion, as compared with $69 million for the fourth ...esults was the first of two installment payments o...urth quarter 2008 results was a one-time $1.8 mill...
(Date:12/1/2009)..., CAMBRIDGE, Mass., Dec. 1 To a...stry and to promote its potential, a group of indi...he Synthetic Biology Industry Association (SynBIA)...f the association is to provide a forum for indivi...industry, address its opportunities and its challe...
(Date:12/1/2009)...N FRANCISCO, Dec. 1 The Burrill Bi...f the value it lost in October. The Select,s gain ... month for the general markets with the Dow up 6.5...he gains held firm in the final two trading days o...h Thanksgiving holiday shopping and Dubai,s report...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4
...d in Indonesia, Thailand and Sri Lanka when the ch...lled the wealthier nations of the world stingy for...d off the remark as yet another reason to dislike ...have done, anyway: They opened their hearts and wa...able outpouring of private and corporate relief f...
...VoIP, may have found the missing link that would e...e a lot of telephone companies go into a state of ...paralyzed. , ,The telcos and cable companies are b...sue of delivering voice over the Internet and to b...evices. This enables them to provide the end-user ...
...ve Ophir Creek in Alaska. Credit: Alaska Division ... rural Alaskan knowledge can now spread globally t...nmental Remote Sensing Center and the Alaska Divis...MapTeach effort, or Mapping Technology Experience...combine geospatial information with traditional kn...
Other Biology Technology:Are we stingy on tsunami relief? Not when private giving is counted 2Are we stingy on tsunami relief? Not when private giving is counted 3The day the old telephony died 2The day the old telephony died 3MapTeach project spreads Alaskan geographic knowledge online 2MapTeach project spreads Alaskan geographic knowledge online 3
(Date:12/2/2009)...s of carbon about a nanometer in diameterhave been...ultrastrong fibers, electrical wires in molecular ...ells. Thanks to a new development by researchers a...gy (NIST) and five partners, you can add one more ... of an aggressive form of breast cancer. , HER2 ...
(Date:12/2/2009)...cording to the National Institute of Health, 40 pe...abetes already have some stage of diabetic retinop...caused by leaky blood vessels, is a major cause of...he most feared diabetic complications. In fact, u...s for 10 years or more will experience some form o...
(Date:12/1/2009)...Dec. 1 GestureTek Inc. today annou...ey, portable, plug and play interactive projection...inment and touring promotions. GestureTek is the i...enabled gesture recognition technology for interac...ms. ,, Guaranteed for quality, the CUBE has TUV...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 1Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 2Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 3Regeneron Announces September 2009 Investment Conference Presentations 56871 1Regeneron Announces September 2009 Investment Conference Presentations 56871 2BayCare Outpatient Center Opens in Westchase Florida 56869 1
...researchers have used an experimental therapy in m...in a leading cause of inherited blindness. , The t...Research, involves injecting the eye with a bit of...lps disable the gene. , Normally the gene is es... of it are passed from generation to generation in...
...out of Africa some 60,000 years ago to populate th...he bacterium Helicobacter pylori, which causes gas... bacterium spread throughout the entire world. Thi...am of scientists led by Mark Achtman from the Max ...Germany. The researchers also discovered that diff...
... but they keep growing because they don,t react to...ers at Washington University School of Medicine in...ssenger into cancer cells that forces them to resp... the most sinister pathogens around ?HIV. , "HIV k...s of cells," says senior author William G. Hawkins...
Other Biology News:Gene therapy for blindness clears hurdle in mice 2Out of Africa -- Bacteria, as well 2HIV protein enlisted to help kill cancer cells 2HIV protein enlisted to help kill cancer cells 3
GIBCO Schneider's Drosophila Medium (1X) liquid from Invitrogen
Virology LabFax from Promega
GIBCO IPL-41 Insect Medium (1X) liquid from Invitrogen
GIBCO Newborn Calf Serum from Invitrogen
Biology Products: